BISSON SABINE (Chief Operating Officer) reported 2 transactions at RETENSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/13/2026ACC: 0001213900-26-109156
Officer· Chief Operating Officer
Since Oct 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.12K acquired · 4.12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.61K
Price / share
—
Trade value
—
% of position
New position
10/13/2026
0.00→1.61K
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
155.4%
10/13/2026
1.61K→4.12K
Total
Net shares
+4.12K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/13/2026 | C · Conversion | +1.61K | — | — | New position | 0.00 | 1.61K |
| Common Stock Direct | 10/13/2026 | C · Conversion | +2.50K | — | — | 155.4% | 1.61K | 4.12K |
| Total | +4.12K | $0.00 | ||||||
Derivative Transactions2
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
1.61K shares
Shares
−1.61K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
Series B Convertible Preferred Stock
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock1.61K shares | 10/13/2026 | C · Conversion | −1.61K | — | 0.00 | |
| Series B Convertible Preferred Stock Direct | Common Stock2.50K shares | 10/13/2026 | C · Conversion | −2.50K | — | 0.00 |